Compare Nuwellis Inc (NUWE) vs Sezzle Inc (SEZL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Sezzle Inc — how do they compare? Nuwellis Inc trades at $2.94 (market cap $1.09M), while Sezzle Inc trades at $178.66 (market cap $5.78B). The key difference: Sezzle Inc is far larger — about 5302.8× Nuwellis Inc's market cap, and Sezzle Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | SEZL | |
|---|---|---|
Market Cap | $1.09M | $5.78B |
Sector | Technology | Technology |
52-Week High | $527.46 | $188.55 |
52-Week Low | $2.80 | $50.97 |
Enterprise Value | -$722.58K | $5.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $3.00, up 5.26% over 24 hours, following a recent 35:1 reverse stock split effective June 26, 2026. The stock shows a bearish technical signal with all moving averages indicating sell. Fundamentally, the company reported a net loss of $17.52M in 2025, with negative profit margins, though revenue grew to $8.27M. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026.
Outlook remains challenging due to persistent losses and high cash burn, but strategic initiatives in pediatric cardiorenal care and new patents offer growth potential. Key risks include negative ROE, reliance on financing, and competitive pressures. Analyst consensus is split evenly between Buy and Hold, reflecting cautious optimism amid financial headwinds.
Sezzle Inc. (SEZL) trades at $171.76, down 1.67% today, with a bullish technical signal from moving averages and a neutral RSI near 50. The stock shows strong fundamental momentum, with Q1 2026 EPS of $1.43 beating estimates of $1.24, and robust profitability metrics including a 30.83% net income margin and 91.95% ROE. Recent news highlights subscriber growth of 48.4% year-over-year and product expansions, supporting the positive sentiment.
Outlook remains favorable due to consistent earnings beats and raised guidance, but risks include high valuation multiples (P/E of 41) and competitive pressures in the BNPL sector. Analyst consensus is a Moderate Buy with a $162 price target, suggesting potential downside from current levels, though the high target of $190 indicates upside if growth persists.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →
